News

Masimo LHC Ltd offer for LiDCO Group Plc

London – Paul Hastings LLP, a leading global law firm, announced today that it is advising Masimo LHC Limited, a wholly-owned indirect subsidiary of Masimo Corporation (“Masimo”), on its recommended cash acquisition of the entire issued and to be issued share capital of LidCo Group plc (“LidCo”).

The acquisition was

on 2 November 2020.

Masimo is a global medical technology company that develops, manufactures, distributes, and licenses innovative patient monitoring technologies, medical devices, and a wide array of sensors. LidCo is a market leader for the provision of advanced hemodynamic monitoring products in the UK and has a growing presence in the US and many other international markets.

The Paul Hastings team was led by London partner 

 and senior associate 

David Prowse

with support from corporate associates 

Catherine Kennedy

and Rebecca Denton. The Paul Hastings team also included employment partner

Suzanne Horne

 and associate

Aashna Parekh

and tax partner

Jiten Tank

 and associate

Hannah Gray

. Masimo relationship partner

Jeff Hartlin

and associate Regina Mendoza advised on the US securities aspects of the transaction.

At Paul Hastings, our purpose is clear — to help our clients and people navigate new paths to growth. With a strong presence throughout Asia, Europe, Latin America, and the U.S., Paul Hastings is recognized as one of the world’s most innovative global law firms.